Radiopharm Theranostics Limited Adjustments For Depreciation And Amortisation Expense
Radiopharm Theranostics Limited (RADX) reported Adjustments For Depreciation And Amortisation Expense of $2.60 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2025-09-18
| Period end | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|
| 2025-06-30 | $2.60M 20-F · filed 2025-09-18 |
| 2024-06-30 | $3.13M 20-F · filed 2025-09-18 |
| 2023-06-30 | $3.30M 20-F · filed 2025-09-18 |